BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 21943197)

  • 1. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
    Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
    Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains.
    Brügmann A; Eld M; Lelkaitis G; Nielsen S; Grunkin M; Hansen JD; Foged NT; Vyberg M
    Breast Cancer Res Treat; 2012 Feb; 132(1):41-9. PubMed ID: 21512768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.
    Micsik T; Kiszler G; Szabó D; Krecsák L; Hegedűs C; Tibor K; Molnár B
    Pathol Oncol Res; 2015 Sep; 21(4):1005-11. PubMed ID: 25788005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer.
    Mohammed ZM; Going JJ; McMillan DC; Orange C; Mallon E; Doughty JC; Edwards J
    Histopathology; 2012 Oct; 61(4):675-84. PubMed ID: 22747525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
    Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
    Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.
    Nassar A; Cohen C; Albitar M; Agersborg SS; Zhou W; Lynch KA; Heyman ER; Lange H; Siddiqui MT
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):212-7. PubMed ID: 21475038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.
    Turashvili G; Leung S; Turbin D; Montgomery K; Gilks B; West R; Carrier M; Huntsman D; Aparicio S
    BMC Cancer; 2009 May; 9():165. PubMed ID: 19476653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Validation Study of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Digital Imaging Analysis and its Correlation with Human Epidermal Growth Factor Receptor 2 Fluorescence
    Hartage R; Li AC; Hammond S; Parwani AV
    J Pathol Inform; 2020; 11():2. PubMed ID: 32154039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of analytical accuracy of HER2 status in patients with breast cancer: Comparison of HER2 GPA with HER2 IHC and HER2 FISH.
    Jensen SG; Thomas PE; Christensen IJ; Balslev E; Hansen A; Høgdall E
    APMIS; 2020 Nov; 128(11):573-582. PubMed ID: 32860265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the change in cutoff values for human epidermal growth factor receptor 2 status by immunohistochemistry and fluorescence in situ hybridization: a study comparing conventional brightfield microscopy, image analysis-assisted microscopy, and interobserver variation.
    Atkinson R; Mollerup J; Laenkholm AV; Verardo M; Hawes D; Commins D; Engvad B; Correa A; Ehlers CC; Nielsen KV
    Arch Pathol Lab Med; 2011 Aug; 135(8):1010-6. PubMed ID: 21809992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.
    Sun H; Kang EY; Chen H; Sweeney KJ; Suchko M; Wu Y; Wen J; Krishnamurthy S; Albarracin CT; Ding QQ; Foo WC; Sahin AA
    Breast Cancer Res Treat; 2024 Jun; 205(2):403-411. PubMed ID: 38441847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
    Li AC; Zhao J; Zhao C; Ma Z; Hartage R; Zhang Y; Li X; Parwani AV
    Breast Cancer Res Treat; 2020 Apr; 180(2):321-329. PubMed ID: 32002765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study.
    van der Logt EM; Kuperus DA; van Setten JW; van den Heuvel MC; Boers JE; Schuuring E; Kibbelaar RE
    PLoS One; 2015; 10(4):e0123201. PubMed ID: 25844540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
    Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
    BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.
    Hanna WM; Barnes PJ; Chang MC; Gilks CB; Magliocco AM; Rees H; Quenneville L; Robertson SJ; SenGupta SK; Nofech-Mozes S
    J Clin Oncol; 2014 Dec; 32(35):3967-73. PubMed ID: 25385731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.
    Tuominen VJ; Tolonen TT; Isola J
    Histopathology; 2012 Apr; 60(5):758-67. PubMed ID: 22296215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image analysis of HER2 immunohistochemical staining. Reproducibility and concordance with fluorescence in situ hybridization of a laboratory-validated scoring technique.
    Minot DM; Voss J; Rademacher S; Lwin T; Orsulak J; Caron B; Ketterling R; Nassar A; Chen B; Clayton A
    Am J Clin Pathol; 2012 Feb; 137(2):270-6. PubMed ID: 22261453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques.
    Ellis CM; Dyson MJ; Stephenson TJ; Maltby EL
    J Clin Pathol; 2005 Jul; 58(7):710-4. PubMed ID: 15976337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
    Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
    Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
    Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
    World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.